000274161 001__ 274161
000274161 005__ 20240229154927.0
000274161 0247_ $$2doi$$a10.1186/s13053-023-00247-3
000274161 0247_ $$2pmid$$apmid:36882784
000274161 0247_ $$2ISSN$$a1731-2302
000274161 0247_ $$2ISSN$$a1897-4287
000274161 0247_ $$2altmetric$$aaltmetric:143400626
000274161 037__ $$aDKFZ-2023-00463
000274161 041__ $$aEnglish
000274161 082__ $$a610
000274161 1001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b0$$eFirst author$$udkfz
000274161 245__ $$aAre population level familial risks and germline genetics meeting each other?
000274161 260__ $$aHeidelberg$$bSpringer$$c2023
000274161 3367_ $$2DRIVER$$aarticle
000274161 3367_ $$2DataCite$$aOutput Types/Journal article
000274161 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1678271185_6777$$xReview Article
000274161 3367_ $$2BibTeX$$aARTICLE
000274161 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000274161 3367_ $$00$$2EndNote$$aJournal Article
000274161 500__ $$a#EA:C020#
000274161 520__ $$aLarge amounts of germline sequencing data have recently become available and we sought to compare these results with population-based family history data. Family studies are able to describe aggregation of any defined cancers in families. The Swedish Family-Cancer Database is the largest of its kind in the world, covering the Swedish families through nearly a century with all cancers in family members since the start of national cancer registration in 1958. The database allows estimation of familial risks, ages of cancer onset and the proportion of familial cancer in different family constellations. Here, we review the proportion of familial cancer for all common cancers and specify them based on the number of affected individuals. With the exception of a few cancers, age of onset of familial cancer is not different from all cancers combined. The highest proportions of familial cancer were found for prostate (26.4%), breast (17.5%) and colorectal (15.7%) cancers, but the proportions of high-risk families with multiple affected individuals were only 2.8%, 1% and 0.9%, respectively. A large sequencing study on female breast cancer found that BRCA1 and BRCA2 mutations could account for 2% of the cases (subtracting the proportions in healthy individuals) and that all germline mutations accounted for 5.6% of the cases. Early age of onset was a distinct feature of only BRCA mutations. In heritable colorectal cancer, Lynch syndrome genes dominate. Large studies on penetrance in Lynch syndrome have shown an approximately linear increase in risk from 40-50 years up to age 80 years. Interesting novel data revealed a strong modification of familial risk by unknown factors. High-risk germline genetics of prostate cancer is characterized by BRCA and other DNA repair genes. HOXB13 encodes a transcription factor which contributes to germline risk of prostate cancer. A strong interaction was shown with a polymorphism in the CIP2A gene. The emerging germline landscape of common cancers can be reasonably accommodated by family data on these cancers as to high-risk proportions and age of onset.
000274161 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000274161 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000274161 650_7 $$2Other$$aFamilial proportion
000274161 650_7 $$2Other$$aFamilial risk
000274161 650_7 $$2Other$$aFamily-Cancer Database
000274161 650_7 $$2Other$$aHigh-risk families
000274161 650_7 $$2Other$$aNation-wide study
000274161 7001_ $$aLi, Xinjun$$b1
000274161 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b2$$udkfz
000274161 7001_ $$aEng, Charis$$b3
000274161 773__ $$0PERI:(DE-600)2233352-6$$a10.1186/s13053-023-00247-3$$gVol. 21, no. 1, p. 3$$n1$$p3$$tHereditary cancer in clinical practice$$v21$$x1731-2302$$y2023
000274161 909CO $$ooai:inrepo02.dkfz.de:274161$$pVDB
000274161 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000274161 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000274161 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000274161 9141_ $$y2023
000274161 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-09
000274161 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-09
000274161 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-09
000274161 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-09
000274161 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000274161 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000274161 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-25
000274161 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T15:09:24Z
000274161 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T15:09:24Z
000274161 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review$$d2023-04-12T15:09:24Z
000274161 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000274161 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000274161 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-25
000274161 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-25
000274161 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000274161 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000274161 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000274161 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000274161 980__ $$ajournal
000274161 980__ $$aVDB
000274161 980__ $$aI:(DE-He78)C020-20160331
000274161 980__ $$aI:(DE-He78)B062-20160331
000274161 980__ $$aI:(DE-He78)HD01-20160331
000274161 980__ $$aUNRESTRICTED